Manas Kinra

Manipala, KA, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Investigation of p-coumaric acid on intracerebroventricular lipopolysaccharide-induced spatial memory impairment and neuroinflammation in rats.

Investigation of p-coumaric acid on intracerebroventricular lipopolysaccharide-induced spatial memory impairment and neuroinflammation in rats.

Journal: Behavioural pharmacology

Published: May 06, 2025

Hydroxycinnamates alleviate chronic unpredictable mild stress‑induced depressive‑like behavior and neuroinflammation in mice.

Hydroxycinnamates alleviate chronic unpredictable mild stress‑induced depressive‑like behavior and neuroinflammation in mice.

Journal: Acta neurobiologiae experimentalis

Published: January 14, 2025

Involvement of NLRP3 inflammasome pathway in the protective mechanisms of ferulic acid and p-coumaric acid in LPS-induced sickness behavior and neuroinflammation in mice.

Involvement of NLRP3 inflammasome pathway in the protective mechanisms of ferulic acid and p-coumaric acid in LPS-induced sickness behavior and neuroinflammation in mice.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: August 11, 2023

Effect of chronic low-dose treatment with chitooligosaccharides on microbial dysbiosis and inflammation associated chronic ulcerative colitis in Balb/c mice.

Effect of chronic low-dose treatment with chitooligosaccharides on microbial dysbiosis and inflammation associated chronic ulcerative colitis in Balb/c mice.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 14, 2023

Involvement of indoleamine 2, 3-dioxygenase (IDO) and brain-derived neurotrophic factor (BDNF) in the neuroprotective mechanisms of ferulic acid against depressive-like behaviour.

Involvement of indoleamine 2, 3-dioxygenase (IDO) and brain-derived neurotrophic factor (BDNF) in the neuroprotective mechanisms of ferulic acid against depressive-like behaviour.

Journal: Metabolic brain disease

Published: May 12, 2023

Putative involvement of sirtuin modulators in LPS-induced sickness behaviour in mice.

Putative involvement of sirtuin modulators in LPS-induced sickness behaviour in mice.

Journal: Metabolic brain disease

Published: November 09, 2021

Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma.

Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma.

Journal: Scientific reports

Published: September 02, 2021

Reviewing the importance of TLR-NLRP3-pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors.

Reviewing the importance of TLR-NLRP3-pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors.

Journal: Scandinavian journal of immunology

Published: June 24, 2021

Erratum: Neuroprotective effect of Mulmina™ against chemotherapy-induced cognitive decline in normal mice.

Erratum: Neuroprotective effect of Mulmina™ against chemotherapy-induced cognitive decline in normal mice.

Journal: Biomedical reports

Published: May 19, 2021

Remedial effects of caffeine against depressive-like behaviour in mice by modulation of neuroinflammation and BDNF.

Remedial effects of caffeine against depressive-like behaviour in mice by modulation of neuroinflammation and BDNF.

Journal: Nutritional neuroscience

Published: April 05, 2021

Animal models of chemotherapy-induced cognitive decline in preclinical drug development.

Animal models of chemotherapy-induced cognitive decline in preclinical drug development.

Journal: Psychopharmacology

Published: December 05, 2020

Inhibition of NLRP3-inflammasome mediated IL-1β release by phenylpropanoic acid derivatives: in-silico and in-vitro approach.

Inhibition of NLRP3-inflammasome mediated IL-1β release by phenylpropanoic acid derivatives: in-silico and in-vitro approach.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: September 09, 2020

Showing 1-12 of 30

Last Updated: 09/26/2026